心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2021意见书：老年心衰患者从入院到出院的诊断和管理

2021-08-10 国外心血管相关专家小组（统称） Journal of Clinical Medicine

老年心衰患者

老年人恶化性心力衰竭（HF）的多学科管理可提高患者生存率。为确保患者能够获得充分的护理，本文主要针对老年HF患者从入院到出院的管理提供实用指导。

中文标题：

2021意见书：老年心衰患者从入院到出院的诊断和管理

英文标题：

Diagnosis and Management of Heart Failure in Elderly Patients from Hospital Admission to Discharge: Position Paper

发布机构：

国外心血管相关专家小组（统称）

发布日期：

2021-08-10

简要介绍：

老年人恶化性心力衰竭（HF）的多学科管理可提高患者生存率。为确保患者能够获得充分的护理，本文主要针对老年HF患者从入院到出院的管理提供实用指导。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021意见书：老年心衰患者从入院到出院的诊断和管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=f38d21c002202e8f, title=2021意见书：老年心衰患者从入院到出院的诊断和管理, enTitle=Diagnosis and Management of Heart Failure in Elderly Patients from Hospital Admission to Discharge: Position Paper, guiderFrom=Journal of Clinical Medicine, authorId=0, author=, summary=老年人恶化性心力衰竭（HF）的多学科管理可提高患者生存率。为确保患者能够获得充分的护理，本文主要针对老年HF患者从入院到出院的管理提供实用指导。, cover=https://img.medsci.cn/20211012/1634014836463_5579292.jpg, journalId=0, articlesId=null, associationId=738, associationName=国外心血管相关专家小组（统称）, associationIntro=null, copyright=0, guiderPublishedTime=Tue Aug 10 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">老年人恶化性心力衰竭（HF）的多学科管理可提高患者生存率。为确保患者能够获得充分的护理，本文主要针对老年HF患者从入院到出院的管理提供实用指导。</span></p>, tagList=[TagDto(tagId=115840, tagName=老年心衰患者)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=448, guiderKeyword=心衰, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2438, appHits=336, showAppHits=0, pcHits=659, showPcHits=2102, likes=2, shares=32, comments=8, approvalStatus=1, publishedTime=Tue Oct 12 13:25:12 CST 2021, publishedTimeString=2021-08-10, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Tue Oct 12 13:08:11 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Thu Jan 04 17:51:03 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021意见书：老年心衰患者从入院到出院的诊断和管理.pdf)])
2021意见书：老年心衰患者从入院到出院的诊断和管理.pdf
下载请点击：
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2115377, encodeId=271c21153e739, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0268276238, createdName=ms5000000866919417, createdTime=Sun Feb 19 11:17:41 CST 2023, time=2023-02-19, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1186739, encodeId=59551186e3958, content=学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3815704614, createdName=空城计1, createdTime=Fri Jan 21 10:34:33 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068368, encodeId=997010683689e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201028/d6c265fe42984d23ac7b9fcf59444217/fd5db9b6f8154f89b432b89a73dcc3ee.jpg, createdBy=13f55429882, createdName=j3x, createdTime=Tue Nov 09 07:03:32 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067057, encodeId=01f4106e05791, content=厉害了，又学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65aa5643711, createdName=小白努力长高高, createdTime=Thu Nov 04 21:30:54 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064858, encodeId=3d4e1064858a0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=109b1453233, createdName=zhangguopo999, createdTime=Thu Oct 28 23:56:41 CST 2021, time=2021-10-28, status=1, ipAttribution=)]
    2023-02-19 ms5000000866919417 来自新疆

    学习学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2115377, encodeId=271c21153e739, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0268276238, createdName=ms5000000866919417, createdTime=Sun Feb 19 11:17:41 CST 2023, time=2023-02-19, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1186739, encodeId=59551186e3958, content=学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3815704614, createdName=空城计1, createdTime=Fri Jan 21 10:34:33 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068368, encodeId=997010683689e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201028/d6c265fe42984d23ac7b9fcf59444217/fd5db9b6f8154f89b432b89a73dcc3ee.jpg, createdBy=13f55429882, createdName=j3x, createdTime=Tue Nov 09 07:03:32 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067057, encodeId=01f4106e05791, content=厉害了，又学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65aa5643711, createdName=小白努力长高高, createdTime=Thu Nov 04 21:30:54 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064858, encodeId=3d4e1064858a0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=109b1453233, createdName=zhangguopo999, createdTime=Thu Oct 28 23:56:41 CST 2021, time=2021-10-28, status=1, ipAttribution=)]
    2022-01-21 空城计1

    学习下

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2115377, encodeId=271c21153e739, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0268276238, createdName=ms5000000866919417, createdTime=Sun Feb 19 11:17:41 CST 2023, time=2023-02-19, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1186739, encodeId=59551186e3958, content=学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3815704614, createdName=空城计1, createdTime=Fri Jan 21 10:34:33 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068368, encodeId=997010683689e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201028/d6c265fe42984d23ac7b9fcf59444217/fd5db9b6f8154f89b432b89a73dcc3ee.jpg, createdBy=13f55429882, createdName=j3x, createdTime=Tue Nov 09 07:03:32 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067057, encodeId=01f4106e05791, content=厉害了，又学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65aa5643711, createdName=小白努力长高高, createdTime=Thu Nov 04 21:30:54 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064858, encodeId=3d4e1064858a0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=109b1453233, createdName=zhangguopo999, createdTime=Thu Oct 28 23:56:41 CST 2021, time=2021-10-28, status=1, ipAttribution=)]
    2021-11-09 j3x

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2115377, encodeId=271c21153e739, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0268276238, createdName=ms5000000866919417, createdTime=Sun Feb 19 11:17:41 CST 2023, time=2023-02-19, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1186739, encodeId=59551186e3958, content=学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3815704614, createdName=空城计1, createdTime=Fri Jan 21 10:34:33 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068368, encodeId=997010683689e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201028/d6c265fe42984d23ac7b9fcf59444217/fd5db9b6f8154f89b432b89a73dcc3ee.jpg, createdBy=13f55429882, createdName=j3x, createdTime=Tue Nov 09 07:03:32 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067057, encodeId=01f4106e05791, content=厉害了，又学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65aa5643711, createdName=小白努力长高高, createdTime=Thu Nov 04 21:30:54 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064858, encodeId=3d4e1064858a0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=109b1453233, createdName=zhangguopo999, createdTime=Thu Oct 28 23:56:41 CST 2021, time=2021-10-28, status=1, ipAttribution=)]
    2021-11-04 小白努力长高高

    厉害了，又学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2115377, encodeId=271c21153e739, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0268276238, createdName=ms5000000866919417, createdTime=Sun Feb 19 11:17:41 CST 2023, time=2023-02-19, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1186739, encodeId=59551186e3958, content=学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3815704614, createdName=空城计1, createdTime=Fri Jan 21 10:34:33 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068368, encodeId=997010683689e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201028/d6c265fe42984d23ac7b9fcf59444217/fd5db9b6f8154f89b432b89a73dcc3ee.jpg, createdBy=13f55429882, createdName=j3x, createdTime=Tue Nov 09 07:03:32 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067057, encodeId=01f4106e05791, content=厉害了，又学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65aa5643711, createdName=小白努力长高高, createdTime=Thu Nov 04 21:30:54 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064858, encodeId=3d4e1064858a0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=109b1453233, createdName=zhangguopo999, createdTime=Thu Oct 28 23:56:41 CST 2021, time=2021-10-28, status=1, ipAttribution=)]
    2021-10-28 zhangguopo999

    学习

    0

拓展阅读

加拿大心衰诊疗指南（2010更新）：少数民族人口，心脏衰竭和怀孕，疾病管理，和质量改进/保证方案心力衰竭

加拿大心血管学会(CCS,Canadian Cardiovascular Society) · 2010-04-01

2010ESC心衰器械治疗指南

欧洲心脏病学会(ESC,European Society of Cardiology) · 2010-06-10

加拿大心衰诊疗指南（2011更新）：睡眠呼吸暂停,肾脏功能障碍、机械辅助循环和姑息治疗

加拿大心血管学会(CCS,Canadian Cardiovascular Society) · 2011-07-30

2011 ACCF/AHA/AMA-PCPI 成人心衰性能指标

美国心脏病学会基金会(ACCF,American College of Cardiology Foundation) · 2012-04-23

2012 右心衰竭诊断和治疗中国专家共识

中华医学会心血管病学分会(Chinese Society of Cardiology) · 2012-06-01

加拿大心衰诊疗指南（2012更新）：急慢性心衰

加拿大心血管学会(CCS,Canadian Cardiovascular Society) · 2012-12-30